FDA, industry preaching opposing CBD narratives on Capitol Hill
Lawmakers on Capitol Hill are hearing starkly different messages from FDA and hemp industry stakeholders on the safety profile of cannabidiol (CBD).
Source: naturalproductsinsider.com